JPMorgan Raises Globe Life Price Target to $181 After Q4 $1.52B Revenue and FY26 EPS Outlook
JPMorgan lifted Globe Life’s price target to $181 from $180 and reaffirmed an Overweight rating following the insurer’s fourth-quarter report. Globe Life posted Q4 revenue of $1.52 billion versus $1.53 billion expected and projected fiscal 2026 EPS of $14.95 to $15.65 compared with a $15.03 consensus.
1. JPMorgan Raises Price Target
On February 6, 2026, JPMorgan analyst Jimmy Bhullar increased his price target on Globe Life to $181 from $180 and maintained an Overweight rating, reflecting confidence in the insurer’s earnings potential.
2. Q4 Revenue Miss
Globe Life reported fourth-quarter revenue of $1.52 billion, narrowly missing the $1.53 billion consensus, with investor attention focused on forward earnings rather than the slight top-line shortfall.
3. FY2026 EPS Outlook
Management provided fiscal 2026 EPS guidance of $14.95 to $15.65 per share, exceeding the $15.03 consensus and indicating potential continued earnings growth in the upcoming year.